Alternatives
Alternatives to Invega Sustenna 156 mg/1 mL injection
1 other presentations of Paliperidone palmitate 156 mg/1 mL injection
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Paliperidone palmitate), strength (156 mg/1 mL) and dosage form (injection) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Invega Sustenna 156 mg/1 mL injectionThis pageIntramuscular | Janssen Pharmaceuticals | US FDA | 1 syringe of 1 mL | Store at room temperature (25 °C, 77 °F), excursions between 15 °C and 30 °C (between 59 °F and 86 °F) are permitted. | On request | — | Available on request |
| Erzofri extended-release 156 mg/1 mL injectionIntramuscular | Shandong Luye Pharmaceutical | US FDA | 1 syringe of 1 mL | Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F to 86°F). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Invega Sustenna 156 mg/1 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.